.png)
Baker Hughes Forecast, price target & analysts
Baker Hughes Target price 2026 - Analyst rating & recommendation
Baker Hughes Classifications & Recommendation
Baker Hughes Price Target
| Target Price | $75.48 |
| Price | $56.00 |
| Potential | 34.79% |
| Number of Estimates | 25 |
| 25 Analysts have issued a price target Baker Hughes 2027 . The average Baker Hughes target price is $75.48. This is 34.79% higher than the current stock price. The highest price target is $89.25 59.38% , the lowest is $51.51 8.02% . | |
| A rating was issued by 29 analysts: 23 Analysts recommend Baker Hughes to buy, 5 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Baker Hughes stock has an average upside potential 2027 of 34.79% . Most analysts recommend the Baker Hughes stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2030
25 Analysts have issued a sales forecast Baker Hughes 2026 . The average Baker Hughes sales estimate is
This results in the following potential growth metrics:
26 Analysts have issued an Baker Hughes EBITDA forecast 2026. The average Baker Hughes EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
27 Baker Hughes Analysts have issued a net profit forecast 2026. The average Baker Hughes net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
27 Analysts have issued a Baker Hughes forecast for earnings per share. The average Baker Hughes EPS is
This results in the following potential growth metrics and future valuations:
Current Baker Hughes Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Neutral
➜
Neutral
|
Unchanged | Sep 30 2026 |
| Jefferies |
Buy
➜
Buy
|
Unchanged | Sep 29 2026 |
| Goldman Sachs |
➜
Buy
|
Unchanged | Sep 29 2026 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Sep 14 2026 |
| Susquehanna |
Positive
➜
Positive
|
Unchanged | Sep 10 2026 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Sep 10 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Aug 25 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Sep 30 2026 |
|
Unchanged
Jefferies:
Buy
➜
Buy
|
Sep 29 2026 |
|
Unchanged
Goldman Sachs:
➜
Buy
|
Sep 29 2026 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Sep 14 2026 |
|
Unchanged
Susquehanna:
Positive
➜
Positive
|
Sep 10 2026 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Sep 10 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Aug 25 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
